Drug Database
Back to search

France· FR:61345705

QUININE RENAUDIN 245 mg/ml, solution injectable pour perfusion IV

A quinine product containing chlorhydrate de quinine, registered in France by LABORATOIRE RENAUDIN. The same ATC class is registered in 9 of our 19 countries.

ATC P01BC01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedQUININE RENAUDIN 245 mg/ml, solution …ATCP01BC01REGISTER NO.FR:61345705PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorhydrate de quinineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Quinine is registered in 9 of 19 countries.

Countries holding a registration under ATC P01BC01 (quinine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 3 of them publish a price we can compare per daily dose
Search quinine products by name

Quinine · ATC P01BC01

9 / 19 countries

  • Canada
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE QUININE
Manufacturer
LABORATOIRE RENAUDIN
Country
France (FR)
ATC code
P01BC01
ATC class
Quinine
Defined daily dose
1.5 g, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400935400918
    10 ampoule(s) en verre de 2 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

496 interactions on record for quinine.

Graded by severity as the source publishes them — 102 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check quinine against other medicinesHow interaction checks work

Quinine · interactions on record

496 records

  • 102 severe
  • 378 moderate
  • 16 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Sodium picosulfateA06AB08severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Quinine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All quinine products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Cyprus · Quinine Sulphate Remedica
  • Germany · Chinin Axunio, Chinin Divapharma
  • Denmark · Chininsulfate Axunio
  • United Kingdom (Northern Ireland) · Quinine Bisulfate, Quinine Bisulfate Strides Pharma Uk
  • Ireland · Quinine Sulphate Teva
  • Italy · Chinina Cloridrato Agenzia Industrie Difesa - Stabilimento Chimico Farmaceutico Militare, Chinina Cloridrato Galenica Senese
  • Netherlands · A-Qs 200
  • Portugal · Quinina Labesfal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4a15e234-c9a5-4586-a820-ef9057371a4b
GET /v1/drugs/4a15e234-c9a5-4586-a820-ef9057371a4b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61345705",
  "date_amm": "2000-04-12",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE QUININE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about quinine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console